Lisa Lambie is Managing Partner & Chief Impact Officer of Maroon Venture Fund I LP (Maroon Invest Global). Over 25+ years, Lisa has successfully founded and built institutional and entrepreneurial ventures; establishing a track record globally as a visionary executive leader, successful serial entrepreneur, angel investor, investment banker, and institutional investor across private equity, venture capital, venture debt. Maroon Venture Fund is a highly differentiated US-based emerging fund manager investing anchor capital in innovative early-stage ventures (Pre-Seed to Series A) to accelerate innovation and close material funding gaps addressing chronic Population Health and Climate conditions (impacting Population Health) traditionally under-invested in; which disproportionately impact women and economically under-represented demographics. Climate areas are in the Blue Economy, Built Environment, and leveraging AI to accelerate and amplify positive Climate impact. Chronic Population Health areas include autoimmune diseases, cardiovascular conditions, inflammation, environmental allergies, certain cancers, neurological and brain health. Fund's innovation arm manages its US-UK AstraWell Venture Studio for Womens Health, as well as, its Womens Catalytic Climate Fellowship. Fund team has deep expertise and a proven investment track record as institutional LPs and successful venture builders, who have scaled and exited both ventures and funds in Maroon’s target Health and Climate sectors while astutely managing portfolio risk and ability to deliver attractive returns in conjunction with tangible  impact.